G115-0472 Screening compound: N-({1-[(4-chlorophenyl)methyl]piperidin-4-yl}methyl)-5-(6-oxo-1,6-dihydropyridazin-3-yl)thiophene-2-sulfonamide

G115-0472 Screening compound: N-({1-[(4-chlorophenyl)methyl]piperidin-4-yl}methyl)-5-(6-oxo-1,6-dihydropyridazin-3-yl)thiophene-2-sulfonamide
G115-0472 Screening compound: N-({1-[(4-chlorophenyl)methyl]piperidin-4-yl}methyl)-5-(6-oxo-1,6-dihydropyridazin-3-yl)thiophene-2-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G115-0472
N-({1-[(4-chlorophenyl)methyl]piperidin-4-yl}methyl)-5-(6-oxo-1,6-dihydropyridazin-3-yl)thiophene-2-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G115-0472

Molecular Formula

C21H23ClN4O3S2 (C21 H23 ClN4 O3 S2)

Compound Name

N-({1-[(4-chlorophenyl)methyl]piperidin-4-yl}methyl)-5-(6-oxo-1,6-dihydropyridazin-3-yl)thiophene-2-sulfonamide

IUPAC name

N-({1-[(4-chlorophenyl)methyl]piperidin-4-yl}methyl)-5-(6-oxo-16-dihydropyridazin-3-yl)thiophene-2-sulfonamide

SMILES

O=C(C=C1)NN=C1c(s1)ccc1S(NCC1CCN(Cc(cc2)ccc2Cl)CC1)(=O)=O

InChI

InChI=1S/C21H23ClN4O3S2/c22-17-3-1-16(2-4-17)14-26-11-9-15(10-12-26)13-23-31(28,29)21-8-6-19(30-21)18-5-7-20(27)25-24-18/h1-8,15,23H,9-14H2,(H,25,27)

InChI Key

LHNRPANSGCKLKE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14980859

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.02

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.179

Distribution Coefficient, logD

2.954

Water Solubility, LogSw

-4.49

Polar Surface Area

83.885

Acid Dissociation Constant (pKa)

10.40

Base Dissociation Constant (pKb)

8.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

G115-0472 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

KRAS-Targeted Library (16000 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
Targets:
  • Kinases
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with G115-0472 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G115-0472?
Check Price and Availability of G115-0472, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G115-0472 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G115-0472
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G115-0472
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G115-0472 available by request